Literature DB >> 33110253

Finerenone in chronic kidney disease.

Susan J Allison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33110253     DOI： 10.1038/s41581-020-00371-6

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Authors:  George L Bakris; Rajiv Agarwal; Stefan D Anker; Bertram Pitt; Luis M Ruilope; Peter Rossing; Peter Kolkhof; Christina Nowack; Patrick Schloemer; Amer Joseph; Gerasimos Filippatos
Journal:  N Engl J Med       Date:  2020-10-23       Impact factor: 91.245
  1 in total
  1 in total

1.  Shenqi Yanshen Formula (SQYSF) protects against chronic kidney disease by modulating gut microbiota.

Authors:  Ling Zhang; Tai-Jun Zhang; Ying Li; Wei-Jian Xiong
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.